People should always check with a doctor before trying a new approach
Dihexa: Dihexa is derived from angiotensin IV and acts by binding hepatocyte growth factor (HGF) with high affinity, potentiating HGF/c-Met receptor signaling at subthreshold concentrations
While COVID-19 is predominantly a respiratory disease, growing evidence shows that patients with pre-existing cardiovascular disease (CVD) are at higher risk of developing more severe COVID-19, while post-COVID-19 infection, individuals may be prone to CVD 1,2,3
The gastrointestinal effects, including nausea, vomiting, diarrhea, and constipation , affect roughly 40-50% of users at therapeutic doses
Reyes for trial operations leadership